Advances in gene therapy delivery: next-generation transfection reagent for large-scale AAV manufacturing​

Learn more with our expert!
View webinar

Advances in gene therapy delivery: next-generation transfection reagent for large-scale AAV manufacturing

The number of ATMP therapeutic-based medicines for inherited genetic disorders is in constant growth, with a global 32% increase in new clinical trials in the last 4 years. ATMPs have demonstrated their success with already more than ten approved for commercialization.

Attendees will learn:
  • How to improve AAV viral vector yields by focusing on transfection step.
  • How to perform transfection at large scale.
  • How to ensure reproducibility at different production scales.